NASDAQ: VCNX - Vaccinex, Inc.

半年間の収益性: -72.6%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Vaccinex, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Vaccinex, Inc.

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. Its Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease.

さらに詳しく
It has also developed ActivMAb, an antibody drug discovery platform based on a novel method for complex targets, such as multi-pass membrane receptors or large and diverse libraries of full-length human monoclonal antibodies on the surface of pox viruses. The company was incorporated in 2001 and is headquartered in Rochester, New York.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2018-08-09
ISIN US9186401033
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.vaccinex.com
Цена ао 0.61
1日あたりの価格変動: +52.7% (0.61)
週ごとの価格変動: +63.42% (0.57)
月ごとの料金変更: -26.65% (1.27)
3ヶ月間の価格変動: -14.54% (1.09)
半年間の価格変動: -72.6% (3.4)
年間の価格変動: -87.43% (7.41)
3年間の価格推移: -33.94% (1.41)
5年間の価格推移: -82.36% (5.28)
年初からの価格変動: -15.32% (1.1)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 8.37 1
P/BV -2.06 0
P/E 0 0
EV/EBITDA -0.153 0
合計: 3.88

効率

名前 意味 学年
ROA, % -557.73 0
ROE, % 876.29 10
合計: 3.33

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.0108 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % 8.99 2
収益性 Ebitda, % -37.51 0
収益性 EPS, % 1654.11 10
合計: 2.4
さらに詳しく

機関 音量 共有, %
AIGH Capital Management LLC 58362 4.74
Worth Venture Partners, LLC 46720 3.79
Vanguard Group Inc 3444 0.28
Renaissance Technologies, LLC 2293 0.19
Two Sigma Investments, LP 1154 0.09
Geode Capital Management, LLC 1150 0.09
XTX Topco Ltd 838 0.07
Tower Research Capital LLC (TRC) 475 0.04
Group One Trading, L.P. 65 0.01
UBS Group AG 24 0



スーパーバイザー 役職 支払い 生年
Dr. Maurice Zauderer Ph.D. Co-Founder, CEO, President & Director 411.7k 1946 (79 年)
Dr. Elizabeth E. Evans Ph.D. COO and Senior VP of Discovery & Translational Medicine 291.57k 1973 (52 年)
Dr. Ernest S. Smith Ph.D. Senior VP of Research & Chief Scientific Officer 297.25k 1972 (53 年)
Dr. John E. Leonard Ph.D. Senior Vice President of Development N/A 1947 (78 年)
Ms. Jill Sanchez CPA Chief Financial Officer N/A 1972 (53 年)

住所: United States, Rochester. NY, 1895 Mount Hope Avenue - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.vaccinex.com